✦ LIBER ✦

9071 A phase II study of S-1 monotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer, the Central Japan Lung Study Group trial 0404

✍ Scribed by Nishiyama, O.; Taniguchi, H.; Hiramatsu, T.; Baba, K.; Saito, H.; Yamamoto, M.; Imaizumi, K.; Hasegawa, Y.; Suzuki, R.; Shimokata, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of S-1 monotherapy as s

✍ Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

First-Line Single Agent Treatment With G

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB

Phase II study of S-1 monotherapy in pat

✍ M. Wada; M. Yamamoto; S. Ryuge; Y. Nagashima; N. Hayashi; S. Maki; S. Otani; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 278 KB

A phase II study of S-1 chemotherapy wit

✍ Aoe, Keisuke; Takigawa, Nagio; Hotta, Katsuyuki; Maeda, Tadashi; Kishino, Daizo; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 426 KB

Phase II tailored S-1 regimen study of f

✍ Takayuki Shiroyama, Takashi Kijima, Kiyoshi Komuta… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB